Hey Aamir, check out the latest: More on Epstein, Prasad, and Van Naarden

25% off your annual STAT+ subscription is waiting ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

My Account    STAT+ Check out the top stories from March. If you like what you see, join the STAT+ community today – and enjoy 25% off your first year with code LOYAL25. Molly Ferguson for STAT 1   How a Texas couple is getting rich off out-of-network medical bills By Tara Bannow Illustration: Camille MacMillin/STAT; Source photo: Department of Justice 2   A top biotech VC quietly helped Epstein's 'great friend' make a comeback By Damian Garde Adobe 3   FDA is 'not convinced' UniQure's Huntington's therapy has benefit, senior official says By Adam Feuerstein 25% off STAT+ Get 25% off your first year of STAT+ with discount code LOYAL25. SUBSCRIBE NOW More Top Stories 4   Automatic enrollment in Medicare Advantage plans under consideration, top Trump health official says By Tara Bannow 5   The FDA is targeting telehealth marketing of GLP-1 drugs. Who's prescribing them? By Katie Palmer 6   5 lessons from Vinay Prasad's turbulent tenure at the FDA By Matthew Herper 7   A new mystery emerges about Epstein's involvement in Harvard genetics study By Megan Molteni 8   How an outsider crept into Eli Lilly's top ranks — and plans to drive its business forward By Matthew Herper 9   NIH grant awards are again lagging far behind historical averages, analysis shows By Anil Oza 10   Allogene's off-the-shelf CAR-T is nearing an early but pivotal study readout By Adam Feuerstein read more STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us